Sara Rood-Ojalvo

Title: Sara Rood-Ojalvo: Innovator in Corneal Cross-Linking Technology

Introduction

Sara Rood-Ojalvo is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of ophthalmology, particularly in the area of corneal cross-linking. Her innovative approach has the potential to enhance the effectiveness of treatments for various eye conditions.

Latest Patents

Sara Rood-Ojalvo holds a patent for "Systems and methods for corneal cross-linking with pulsed light." This method involves controlling the activation of Riboflavin applied to the eye. The process includes applying Riboflavin to a selected region of the cornea and initiating cross-linking activity by activating the Riboflavin with pulsed light illumination. The parameters of the pulsed light, such as irradiance, dose, and on/off duty cycle, are adjusted based on the photochemical kinetic pathways for Riboflavin cross-linking activity, ensuring optimal photochemical efficiency. She has 1 patent to her name.

Career Highlights

Sara is currently associated with Avedro, Inc., a company that focuses on developing innovative treatments for corneal diseases. Her work at Avedro has positioned her as a key player in advancing eye care technologies.

Collaborations

Sara has collaborated with notable professionals in her field, including William Eddington and David Muller. These collaborations have further enriched her research and development efforts.

Conclusion

Sara Rood-Ojalvo's contributions to corneal cross-linking technology exemplify her commitment to improving eye health. Her innovative methods and collaborations continue to pave the way for advancements in ophthalmology.